You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 211215


✉ Email this page to a colleague

« Back to Dashboard


NDA 211215 describes ANGIOMAX RTU, which is a drug marketed by Maia Pharms Inc and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the ANGIOMAX RTU profile page.

The generic ingredient in ANGIOMAX RTU is bivalirudin. There are fourteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the bivalirudin profile page.
Summary for 211215
Tradename:ANGIOMAX RTU
Applicant:Maia Pharms Inc
Ingredient:bivalirudin
Patents:3
Pharmacology for NDA: 211215
Mechanism of ActionThrombin Inhibitors
Suppliers and Packaging for NDA: 211215
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANGIOMAX RTU bivalirudin SOLUTION;INTRAVENOUS 211215 NDA Endo USA, Inc. 42023-622 42023-622-01 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-622-01) / 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE
ANGIOMAX RTU bivalirudin SOLUTION;INTRAVENOUS 211215 NDA Endo USA, Inc. 42023-622 42023-622-10 10 VIAL, SINGLE-DOSE in 1 CARTON (42023-622-10) / 1 INJECTION, SOLUTION in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength250MG/50ML (5MG/ML)
Approval Date:Jul 25, 2019TE:RLD:Yes
Patent:11,903,993Patent Expiration:May 20, 2039Product Flag?Substance Flag?Delist Request?
Patented Use:USE AS AN ANTICOAGULANT IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)
Patent:11,918,622Patent Expiration:May 20, 2039Product Flag?Substance Flag?Delist Request?
Patented Use:USE AS AN ANTICOAGULANT IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)
Patent:11,992,514Patent Expiration:May 20, 2039Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.